and Steve Neben senior director of project and alliance management...Facet Biotech Corp., of Redwood City, Calif., appointed Ted Llana senior vice president of commercial and corporate development

BiPar Sciences Inc., of Brisbane, Calif., named Sunil Patel vice president of corporate development and marketing and appointed Adrienne Weil legal counsel...It formed its scientific advisory board with the appointments of Dennis Brown, Xandra Breakefield and Richard L. Edelson, and also appointed Johan Skog director of genetics research

Prometheus Laboratories Inc., of San Diego, named Mark Spring senior vice president and chief financial officer...Targanta Therapeutics Corp., of Cambridge, Mass., appointed Stéphane Bancel and Rosemary A. Crane to its board...Trubion Pharmaceuticals Inc., of Seattle, appointed Scott C. Stromatt senior vice president and chief medical officer

Regulus Therapeutics LLC, of Cambridge, Mass., appointed Garry Menzel executive vice president of corporate development and finance...TheraGenetics Ltd., of Cambridge, Mass., and London, appointed Susan E. Bromley global head of R&D and named Kenneth B. Milne UK director of R&D

and Jay Rheingold vice president of chemistry, manufacturing and controls...Richmond, Calif., named Terrence Moore vice president of marketing and sales and Susan Koppy vice president of corporate development

Ikonysis, of New Haven, Conn., named Louise Mawhinney senior vice president and chief financial officer...Lentigen Corp., of Baltimore, named Jim Meade vice president of corporate development

Javelin Pharmaceuticals Inc., of Cambridge, Mass., named Daniel Carr president and said Fred Mermelstein assumed the role of executive director...Oncothyreon Inc., of Bellevue, Wash., named Daniel K. Spiegelman and Stephen K. Burley to its board...Pantec Biosolutions AG, of Ruggell, Leichtenstein, appointed Burkhard Feurstein and Michael Armbruester to its board

MDS Pharma Services, of King of Prussia, Pa., appointed Teresa F. Winslow senior vice president, global business development and James Miskel vice president, strategy and corporate development...Medivation Inc., of San Francisco, appointed Michele D. Bronson vice president, regulatory and quality

Expression Genetics Inc., of Huntsville, Ala., named Khursheed Anwer senior vice president and chief scientific officer and James A. McCarthy senior vice president, corporate development...Febit group, of Medford, Mass., and Heidelberg, Germany, announced its new scientific advisory board with Mark Chee chairman, Karoly Nikolich vice chairman and David Lockhart, Mostafa Ronaghi and Jeffrey Trent as members

Icagen Inc., of Research Triangle Park, N.C., appointed Richard Katz executive vice president of finance and corporate development and chief financial officer and Douglas Krafte vice president of biology and scientific affairs

Gene Express Inc., of Toledo, Ohio, appointed David Lester senior vice president of strategy and corporate development...The firm also named Garen Manyelian chief medical officer and promoted Jennifer Marshall to vice president of corporate development

BiPar Sciences Inc., of Brisbane, Calif., named G. Kirk Raab acting CEO and appointed Eric Malek vice president of corporate development and Deborah Thomas vice president for regulatory affairs

Nitec Pharma AG, of Reinach, Switzerland, appointed Anders Harfstrand CEO and Andrea Buscaglia chief financial officer...Pharmacopeia, of Princeton, N.J., appointed Eric Liebler executive vice present of corporate development and S. David Kimball senior vice president of chemistry and preclinical chemical development

Egalet A/S, of Copenhagen, Denmark, named Michael Fiorini chairman and appointed Peter Nordkild CEO...plc, of Dublin, Ireland, named Jonas Frick and Giles Kerr nonexecutive directors...Micromet Inc., of Bethesda, Md., appointed Mark Reisenauer senior vice president and chief commercial officer

The company also named Heiner Dreismann, Laurence R. McCarthy and Stuart A. Auerbach to its board of directors...The company also appointed Martin Stogniew executive vice president and chief technology officer...ProtAffin AG, of Graz, Austria, named Timothy Wells and Marco Sardinia to its scientific advisory board

ProtoKinetix Inc., of Vancouver, British Columbia, appointed Ross L. Senior president and CEO...Surface Logix, of Boston, appointed Leland Webster vice president of corporate development

Aspreva Pharmaceuticals Corp., of Victoria, Canada, named J. William Freytag, chairman and chief executive officer...Bavarian Nordic AS, of Kvistgard, Denmark, named Anders Hedegaard president and chief executive officer...Orexigen Therapeutics Inc., of San Diego, appointed Heather Turner vice president and general counsel

The company promoted Michael Ellis to senior director of corporate development...TheraQuest Biosciences, of Blue Bell, Pa., appointed Cynthia McCormick and Nathaniel Katz to its scientific advisory board

Ardea Biosciences Inc., of Carlsbad, Calif., appointed John Beck and John Poyhonen to its board of directors...vice president of research and development and chief scientific officer